These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20010364)

  • 21. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.
    Orgeron GM; James CA; Te Riele A; Tichnell C; Murray B; Bhonsale A; Kamel IR; Zimmerman SL; Judge DP; Crosson J; Tandri H; Calkins H
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychological Distress and Quality of Life in Participants Undergoing Genetic Testing for Arrhythmogenic Right Ventricular Cardiomyopathy Caused by TMEM43 p.S358L: Is It Time to Offer Population-Based Genetic Screening?
    Brothers C; Etchegary H; Curtis F; Simmonds C; Houston J; Young TL; Pullman D; Mariathas HH; Connors S; Hodgkinson K
    Public Health Genomics; 2021; 24(5-6):253-260. PubMed ID: 34500452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Arrhythmogenic right ventricular cardiomyopathy as a cause of sudden death in young people--literature review].
    Mazić S; Lazović B; Delić M
    Med Pregl; 2012; 65(9-10):396-404. PubMed ID: 23214333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Calkins H; Corrado D; Marcus F
    Circulation; 2017 Nov; 136(21):2068-2082. PubMed ID: 29158215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autosomal-dominant biventricular arrhythmogenic cardiomyopathy in a large family with a novel in-frame DSP nonsense mutation.
    Singh SM; Casey SA; Berg AA; Abdelhadi RH; Katsiyiannis WT; Bennett MK; Mackey-Bojack S; Duncanson ER; Sengupta JD
    Am J Med Genet A; 2018 Jul; 176(7):1622-1626. PubMed ID: 30160835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Awad MM; Calkins H; Judge DP
    Nat Clin Pract Cardiovasc Med; 2008 May; 5(5):258-67. PubMed ID: 18382419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study.
    Cox MG; van der Zwaag PA; van der Werf C; van der Smagt JJ; Noorman M; Bhuiyan ZA; Wiesfeld AC; Volders PG; van Langen IM; Atsma DE; Dooijes D; van den Wijngaard A; Houweling AC; Jongbloed JD; Jordaens L; Cramer MJ; Doevendans PA; de Bakker JM; Wilde AA; van Tintelen JP; Hauer RN
    Circulation; 2011 Jun; 123(23):2690-700. PubMed ID: 21606396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of novel DSP_p.Q986X genetic variation in arrhythmogenic right ventricular cardiomyopathy.
    Campuzano O; Alcalde M; Berne P; Zorio E; Iglesias A; Navarro-Manchón J; Brugada J; Brugada R
    Eur J Med Genet; 2013 Oct; 56(10):541-5. PubMed ID: 23954618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arrhythmogenic Right Ventricular Cardiomyopathy: A Review of Living and Deceased Probands.
    Blusztein DI; Zentner D; Thompson T; Jayadeva P; Liang D; Wang R; Winship I; James PA; Trainer AH; Kalman JM; Vohra J
    Heart Lung Circ; 2019 Jul; 28(7):1034-1041. PubMed ID: 30126789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
    Schinkel AF
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression.
    Sen-Chowdhry S; Syrris P; Ward D; Asimaki A; Sevdalis E; McKenna WJ
    Circulation; 2007 Apr; 115(13):1710-20. PubMed ID: 17372169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Hershberger RE; Cowan J; Morales A; Siegfried JD
    Circ Heart Fail; 2009 May; 2(3):253-61. PubMed ID: 19808347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arrhythmogenic Cardiomyopathy.
    Corrado D; Basso C; Judge DP
    Circ Res; 2017 Sep; 121(7):784-802. PubMed ID: 28912183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arrhythmogenic right ventricular dysplasia.
    Calkins H
    Curr Probl Cardiol; 2013 Mar; 38(3):103-23. PubMed ID: 23453020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guidelines for the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy.
    Smith W;
    Heart Lung Circ; 2011 Dec; 20(12):757-60. PubMed ID: 21885338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The rhythms of the Rock.
    Strauss S
    CMAJ; 2012 Mar; 184(4):E209-10. PubMed ID: 22311951
    [No Abstract]   [Full Text] [Related]  

  • 37. Arrhythmogenic right-ventricular cardiomyopathy: molecular genetics into clinical practice in the era of next generation sequencing.
    Poloni G; De Bortoli M; Calore M; Rampazzo A; Lorenzon A
    J Cardiovasc Med (Hagerstown); 2016 Jun; 17(6):399-407. PubMed ID: 26990921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary Myocardial Fibrosis as an Alternative Phenotype Pathway of Inherited Cardiac Structural Disorders.
    Junttila MJ; Holmström L; Pylkäs K; Mantere T; Kaikkonen K; Porvari K; Kortelainen ML; Pakanen L; Kerkelä R; Myerburg RJ; Huikuri HV
    Circulation; 2018 Jun; 137(25):2716-2726. PubMed ID: 29915098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic management in Sicilian patients with definite arrhythmogenic right ventricular dysplasia/cardiomyopathy and focus on the role of implantable cardioverter-defibrillator therapy.
    Inciardi RM; Rotolo A; Coppola G; Clemenza F; Giordano U; Lombardo E; Schicchi R; Torcivia R; Arrotti S; Leggio G; Novo S; Assennato P
    Int J Cardiol; 2014 Apr; 172(3):e468-9. PubMed ID: 24485618
    [No Abstract]   [Full Text] [Related]  

  • 40. Duty to warn and genetic disease.
    Hodgkinson K; Pullman D
    Can J Cardiovasc Nurs; 2010; 20(1):12-5. PubMed ID: 20301857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.